SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Cars.com
CARS
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -8.32%2B | -4.66%2.01B | -6.26%1.55B | 6.38%7.78B | 5.91%1.83B | 4.67%2.19B | 8.12%2.11B | 7.03%1.65B | 31.75%7.32B | 7.82%1.73B |
Operating revenue | -8.32%2B | -5.00%1.76B | -6.96%1.32B | 6.38%7.78B | 5.91%1.83B | 4.67%2.19B | 8.87%1.85B | 6.86%1.42B | 31.75%7.32B | 7.82%1.73B |
Cost of revenue | -9.79%1.44B | -7.02%1.42B | -7.88%1.24B | 1.32%5.83B | -1.44%1.36B | -0.04%1.59B | 1.43%1.53B | 5.90%1.35B | 37.78%5.76B | 10.15%1.38B |
Gross profit | -4.37%565.2M | 1.53%592.2M | 0.96%304.9M | 25.09%1.95B | 34.95%472.2M | 19.90%591M | 30.73%583.3M | 12.35%302M | 13.42%1.56B | -0.51%349.9M |
Operating expense | -4.32%141.7M | -4.37%142.4M | 13.82%132.6M | 3.66%569.2M | 10.74%155.7M | 3.21%148.1M | 5.90%148.9M | -6.28%116.5M | 14.85%549.1M | 0.36%140.6M |
Selling and administrative expenses | -10.28%129.1M | -3.59%134.1M | 10.57%129.7M | 5.38%542.8M | 12.66%142.4M | 6.36%143.9M | 3.50%139.1M | -1.43%117.3M | 23.35%515.1M | 1.53%126.4M |
Other operating expenses | 200.00%12.6M | -15.31%8.3M | 462.50%2.9M | -22.35%26.4M | -6.34%13.3M | -48.78%4.2M | 58.06%9.8M | -115.09%-800K | -43.80%34M | -8.97%14.2M |
Operating profit | -4.38%423.5M | 3.55%449.8M | -7.12%172.3M | 36.75%1.38B | 51.22%316.5M | 26.76%442.9M | 42.15%434.4M | 28.37%185.5M | 12.65%1.01B | -1.09%209.3M |
Net non-operating interest income expense | 17.60%-38.4M | 13.92%-40.2M | 20.20%-39.1M | -6.65%-179.6M | 21.43%-37.4M | -1.08%-46.6M | -20.67%-46.7M | -36.49%-49M | -14.01%-168.4M | -31.86%-47.6M |
Non-operating interest income | ---- | ---- | ---- | 1,962.50%16.5M | ---- | ---- | ---- | ---- | -50.00%800K | ---- |
Non-operating interest expense | -17.60%38.4M | -13.92%40.2M | -20.20%39.1M | 15.90%196.1M | 11.36%53.9M | 1.08%46.6M | 20.67%46.7M | 36.49%49M | 13.33%169.2M | 28.38%48.4M |
Other net income (expense) | -196.71%-90.2M | -129.52%-4.9M | -90.32%300K | 187.14%45.4M | 610.91%56.2M | 28.81%-30.4M | 714.81%16.6M | -22.50%3.1M | -141.28%-52.1M | -61.76%-11M |
Special income (charges) | -260.00%-86.4M | -77.25%3.8M | -64.71%600K | 184.09%48.1M | 401.12%53.6M | 45.45%-24M | 735.00%16.7M | -32.00%1.7M | -149.52%-57.2M | -8,800.00%-17.8M |
-Less:Impairment of capital assets | 206.01%86.6M | ---- | ---- | -58.32%28.3M | --0 | -58.26%28.3M | ---- | ---- | 1,376.09%67.9M | --100K |
-Gain on sale of property,plant,equipment | -95.35%200K | -77.25%3.8M | -64.71%600K | 614.02%76.4M | 402.82%53.6M | -81.93%4.3M | 735.00%16.7M | -34.62%1.7M | -91.09%10.7M | -8,750.00%-17.7M |
Other non- operating income (expenses) | 40.63%-3.8M | -8,600.00%-8.7M | -121.43%-300K | -152.94%-2.7M | -61.76%2.6M | -592.31%-6.4M | 97.87%-100K | -6.67%1.4M | -52.34%5.1M | 203.03%6.8M |
Income before tax | -19.40%294.9M | 0.10%404.7M | -4.37%133.5M | 57.99%1.25B | 122.50%335.3M | 40.41%365.9M | 53.03%404.3M | 23.98%139.6M | -9.81%788.1M | -10.67%150.7M |
Income tax | -0.70%85.2M | 2.61%94.4M | 74.10%28.9M | 55.13%299.4M | 269.72%105M | 4.25%85.8M | 44.43%92M | -11.23%16.6M | -3.55%193M | -6.58%28.4M |
Net income | -24.85%208.4M | -0.10%308.3M | -14.89%102.9M | 62.17%934.9M | 90.40%228.1M | 56.58%277.3M | 64.67%308.6M | 31.27%120.9M | -14.01%576.5M | -13.00%119.8M |
Net income continuous Operations | -25.13%209.7M | -0.64%310.3M | -14.96%104.6M | 58.91%945.7M | 88.31%230.3M | 57.09%280.1M | 55.76%312.3M | 30.99%123M | -11.67%595.1M | -11.57%122.3M |
Net income discontinuous operations | 53.57%-1.3M | 45.95%-2M | 19.05%-1.7M | 41.94%-10.8M | 12.00%-2.2M | -133.33%-2.8M | 71.76%-3.7M | -16.67%-2.1M | -463.64%-18.6M | -316.67%-2.5M |
Minority interest income | 0.00%800K | 300K | 0.00%200K | 88.89%1.7M | 75.00%700K | 800K | 0 | -33.33%200K | 325.00%900K | 300.00%400K |
Net income attributable to the parent company | -24.92%207.6M | -0.19%308M | -14.91%102.7M | 62.13%933.2M | 90.45%227.4M | 56.13%276.5M | 64.76%308.6M | 31.48%120.7M | -14.19%575.6M | -13.42%119.4M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -24.92%207.6M | -0.19%308M | -14.91%102.7M | 62.13%933.2M | 90.45%227.4M | 56.13%276.5M | 64.76%308.6M | 31.48%120.7M | -14.19%575.6M | -13.42%119.4M |
Basic earnings per share | -24.52%1.57 | 0.43%2.33 | -14.29%0.78 | 62.12%7.02 | 90.00%1.71 | 56.39%2.08 | 64.54%2.32 | 31.88%0.91 | -14.26%4.33 | -13.46%0.9 |
Diluted earnings per share | -24.64%1.56 | 0.00%2.31 | -14.44%0.77 | 61.95%6.98 | 91.01%1.7 | 55.64%2.07 | 65.00%2.31 | 30.43%0.9 | -14.14%4.31 | -13.59%0.89 |
Dividend per share | 6.98%0.46 | 6.98%0.46 | 6.98%0.46 | 7.50%1.72 | 7.50%0.43 | 7.50%0.43 | 7.50%0.43 | 7.50%0.43 | 8.11%1.6 | 8.11%0.4 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |